The median expression of Ki-67 is 8% (n = 17) in higher-grade meningiomas and 2% (n = 29) in low-grade ones (Table 1), based on available immunohistochemistry data, which is significantly different (p = 0.001). This evidence concerns the gene MKI67 and meningioma.